8,236 Shares in U.S. Physical Therapy, Inc. (NYSE:USPH) Purchased by Semanteon Capital Management LP

Semanteon Capital Management LP acquired a new position in U.S. Physical Therapy, Inc. (NYSE:USPH) during the 4th quarter, according to its most recent filing with the SEC. The fund acquired 8,236 shares of the company’s stock, valued at approximately $767,000. Semanteon Capital Management LP owned approximately 0.05% of U.S. Physical Therapy as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. Quantbot Technologies LP purchased a new position in U.S. Physical Therapy in the 3rd quarter valued at about $82,000. Park Avenue Securities LLC acquired a new position in shares of U.S. Physical Therapy during the 3rd quarter valued at about $232,000. International Assets Investment Management LLC increased its stake in shares of U.S. Physical Therapy by 9,269.0% during the 4th quarter. International Assets Investment Management LLC now owns 2,717 shares of the company’s stock valued at $253,000 after acquiring an additional 2,688 shares during the last quarter. HighTower Advisors LLC increased its stake in shares of U.S. Physical Therapy by 47.2% during the 3rd quarter. HighTower Advisors LLC now owns 2,773 shares of the company’s stock valued at $257,000 after acquiring an additional 889 shares during the last quarter. Finally, Channing Capital Management LLC acquired a new position in shares of U.S. Physical Therapy during the 3rd quarter valued at about $286,000.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on USPH shares. Barrington Research upped their price objective on shares of U.S. Physical Therapy from $120.00 to $122.00 and gave the company an “outperform” rating in a research note on Friday, March 1st. StockNews.com raised shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research note on Monday, March 18th. Finally, JPMorgan Chase & Co. increased their target price on shares of U.S. Physical Therapy from $99.00 to $117.00 and gave the stock an “overweight” rating in a research report on Wednesday, March 13th. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $125.67.

U.S. Physical Therapy Trading Up 0.3 %

USPH traded up $0.35 on Friday, reaching $100.73. 30,485 shares of the company’s stock were exchanged, compared to its average volume of 69,594. The company’s 50 day moving average is $105.04 and its 200-day moving average is $95.35. The company has a market cap of $1.52 billion, a price-to-earnings ratio of 74.58, a PEG ratio of 4.92 and a beta of 1.39. U.S. Physical Therapy, Inc. has a twelve month low of $78.08 and a twelve month high of $124.11. The company has a debt-to-equity ratio of 0.29, a quick ratio of 2.28 and a current ratio of 2.28.

U.S. Physical Therapy (NYSE:USPH) last issued its quarterly earnings data on Wednesday, February 28th. The company reported $0.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.57 by $0.02. U.S. Physical Therapy had a net margin of 4.67% and a return on equity of 8.52%. The company had revenue of $154.80 million during the quarter, compared to the consensus estimate of $150.24 million. During the same quarter last year, the company earned $0.58 earnings per share. U.S. Physical Therapy’s revenue for the quarter was up 9.6% on a year-over-year basis. Equities analysts predict that U.S. Physical Therapy, Inc. will post 2.77 earnings per share for the current year.

U.S. Physical Therapy Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, April 5th. Shareholders of record on Tuesday, March 12th were given a $0.44 dividend. This is an increase from U.S. Physical Therapy’s previous quarterly dividend of $0.43. The ex-dividend date was Monday, March 11th. This represents a $1.76 annualized dividend and a yield of 1.75%. U.S. Physical Therapy’s dividend payout ratio (DPR) is 130.37%.

Insider Buying and Selling at U.S. Physical Therapy

In other U.S. Physical Therapy news, Director Clayton Trier sold 400 shares of the stock in a transaction that occurred on Wednesday, March 13th. The shares were sold at an average price of $107.00, for a total value of $42,800.00. Following the completion of the sale, the director now owns 7,000 shares of the company’s stock, valued at $749,000. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, insider Eric Joseph Williams sold 1,500 shares of the stock in a transaction that occurred on Monday, March 4th. The stock was sold at an average price of $104.96, for a total transaction of $157,440.00. Following the completion of the transaction, the insider now directly owns 19,314 shares in the company, valued at approximately $2,027,197.44. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Clayton Trier sold 400 shares of the stock in a transaction that occurred on Wednesday, March 13th. The shares were sold at an average price of $107.00, for a total value of $42,800.00. Following the transaction, the director now owns 7,000 shares of the company’s stock, valued at $749,000. The disclosure for this sale can be found here. Insiders sold 10,829 shares of company stock valued at $1,141,535 over the last 90 days. 1.80% of the stock is owned by corporate insiders.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.